Terms: = Endocrine gland cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Treatment
328 results:
1. Clinical and genetic analysis of a case of Gitelman syndrome accompanied with Graves disease and adrenocortical adenoma: A case report.
Qiao Y; Zhao J; Wu J; Cao L; Song G; Mao J
Medicine (Baltimore); 2024 Apr; 103(15):e37770. PubMed ID: 38608089
[TBL] [Abstract] [Full Text] [Related]
2. Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth.
Wilkinson AN; Chen R; Coleborn E; Neilson T; Le K; Bhavsar C; Wang Y; Atluri S; Irgam G; Wong K; Yang D; Steptoe R; Wu SY
Cancer Immunol Immunother; 2024 Mar; 73(5):80. PubMed ID: 38554167
[TBL] [Abstract] [Full Text] [Related]
3. A Comparison of Spatial and Phenotypic Immune Profiles of Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions.
Enzler T; Shi J; McGue J; Griffith BD; Sun L; Sahai V; Nathan H; Frankel TL
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474199
[TBL] [Abstract] [Full Text] [Related]
4. [Short-term outcomes of the TRIANGLE operation after neoadjuvant chemotherapy in locally advanced pancreatic cancer].
Xu D; Tu M; Zhang K; Wu PF; Lyu N; Wang QQ; Yin J; Wu Y; Lu ZP; Chen JM; Xi CH; Wei JS; Guo F; Miao Y; Jiang KR
Zhonghua Wai Ke Za Zhi; 2024 Feb; 62(2):147-154. PubMed ID: 38310383
[No Abstract] [Full Text] [Related]
5. [Tolerability and Outcome of Neoadjuvant GS Therapy for Resectable Pancreatic cancer].
Yamashita M; Shimizu J; Sato Y; Noma T; Hagihara K; Yanagimoto Y; Suzuki Y; Ikenaga M; Kawase T; Imamura H; Akagi K; Iwasawa S; Tomita N
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1411-1413. PubMed ID: 38303291
[TBL] [Abstract] [Full Text] [Related]
6. Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
Zhang M; Hu X; Liu L; Wang Y; Jiang J; Li H; Fei W; Zhong T; Jiang Z
Medicine (Baltimore); 2024 Jan; 103(4):e35960. PubMed ID: 38277563
[TBL] [Abstract] [Full Text] [Related]
7. Association between Pancreatoblastoma and Familial Adenomatous Polyposis: Review of the Literature with an Additional Case.
Remo A; Negro S; Bao RQ; d'Angelo E; Alaggio R; Crivellari G; Mammi I; Intini R; Bergamo F; Fassan M; Agostini M; Vitellaro M; Pucciarelli S; Urso EDL
Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38254934
[TBL] [Abstract] [Full Text] [Related]
8. Clinical Significance of Increased Skeletal Muscle Mass During Nab-Paclitaxel Plus Gemcitabine treatment in Patients With Advanced Pancreatic cancer.
Iede K; Yamada T; Ishida T; Tsuda Y; Nakashima S; Tanida T; Matsuyama J; Nakata K; Tominaga S
Pancreas; 2024 Jan; 53(1):e22-e26. PubMed ID: 38157455
[TBL] [Abstract] [Full Text] [Related]
9. Incidence and treatment outcomes of ovarian carcinosarcoma from the national cancer registry of Korea.
Ha HI; Kim JH; Lim J; Song YJ; Won YJ; Lim MC
J Gynecol Oncol; 2024 Jan; 35(1):e31. PubMed ID: 38072401
[TBL] [Abstract] [Full Text] [Related]
10. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic Differences Between Surveillance and Active treatment After Initial Orchiectomy in Patients With Stage I Mixed Germ Cell Tumors of the Testis: A Propensity Score Matching Analysis.
Du Y; Liu L; Zou B; Chen Z; Chen Q; Deng R; Yang P
J Surg Res; 2024 Feb; 294():26-36. PubMed ID: 37857140
[TBL] [Abstract] [Full Text] [Related]
12. Randomized phase II trial of chemoradiotherapy with S-1 versus combination chemotherapy with gemcitabine and S-1 as neoadjuvant treatment for resectable pancreatic cancer (JASPAC 04).
Sugiura T; Toyama H; Fukutomi A; Asakura H; Takeda Y; Yamamoto K; Hirano S; Satoi S; Matsumoto I; Takahashi S; Morinaga S; Yoshida M; Sakuma Y; Iwamoto H; Shimizu Y; Uesaka K
J Hepatobiliary Pancreat Sci; 2023 Nov; 30(11):1249-1260. PubMed ID: 37746781
[TBL] [Abstract] [Full Text] [Related]
13. HIPEC in Ovarian cancer: When and to Whom?
Ates O; Aksel B; Akkus MH; Oner I; Yuksel C; Dogan M
J Coll Physicians Surg Pak; 2023 Sep; 33(9):1001-1005. PubMed ID: 37691361
[TBL] [Abstract] [Full Text] [Related]
14. Efficacy and safety of gemcitabine plus S-1
Zhu Z; Tang H; Ying J; Cheng Y; Wang X; Wang Y; Bai C
Cancer Biol Med; 2023 Aug; 20(10):765-78. PubMed ID: 37646237
[TBL] [Abstract] [Full Text] [Related]
15. A nomogram based on CT texture features to predict the response of patients with advanced pancreatic cancer treated with chemotherapy.
Li J; Du J; Li Y; Meng M; Hang J; Shi H
BMC Gastroenterol; 2023 Aug; 23(1):274. PubMed ID: 37563572
[TBL] [Abstract] [Full Text] [Related]
16. Metastatic pituitary tumors: an institutional case series.
Yearley AG; Chalif EJ; Gupta S; Chalif JI; Bernstock JD; Nawabi N; Arnaout O; Smith TR; Reardon DA; Laws ER
Pituitary; 2023 Oct; 26(5):561-572. PubMed ID: 37523025
[TBL] [Abstract] [Full Text] [Related]
17. IV Thrombolysis With or Without Endovascular treatment for Suspected Ischemic Stroke in Patients With Intracranial Tumors.
Seystahl K; Martinez-Majander N; Salerno A; Beyeler M; Erdur H; Marto JP; Hametner C; Zedde M; Pezzini A; Leker R; Altersberger V; Costamagna G; Serôdio M; Migliaccio L; Pascarella R; Zini A; Mannismäki L; Béjot Y; Jung S; Gensicke H; Padjen V; Ringleb PA; Nolte C; Heldner MR; Michel P; Engelter ST; Curtze S; Weller M; Wegener S
Neurology; 2023 Sep; 101(12):e1241-e1255. PubMed ID: 37463747
[TBL] [Abstract] [Full Text] [Related]
18. Geographical, ethnic, and genetic differences in pancreatic cancer predisposition.
Liew SZH; Ng KW; Ishak NDB; Lee SY; Zhang Z; Chiang J; Ngeow JYY
Chin Clin Oncol; 2023 Jun; 12(3):27. PubMed ID: 37417291
[TBL] [Abstract] [Full Text] [Related]
19. Clinical Efficacy of Neoadjuvant Chemotherapy with Gemcitabine plus S-1 for Resectable Pancreatic Ductal Adenocarcinoma Compared with Upfront Surgery.
Kitano Y; Inoue Y; Takeda T; Oba A; Ono Y; Sato T; Ito H; Ozaka M; Sasaki T; Sasahira N; Baba H; Takahashi Y
Ann Surg Oncol; 2023 Aug; 30(8):5093-5102. PubMed ID: 37140750
[TBL] [Abstract] [Full Text] [Related]
20. Global thyroid cancer incidence trend and age-period-cohort model analysis based on Global Burden of Disease Study from 1990 to 2019.
Xu L; Cao ZX; Weng X; Wang CF
Front Endocrinol (Lausanne); 2023; 14():1133098. PubMed ID: 37124740
[TBL] [Abstract] [Full Text] [Related]
[Next]
